|
1
|
Lee AY and Brady MS: Neoadjuvant
immunotherapy for melanoma. J Surg Oncol. 123:782–788. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
González-Cruz C, Ferrándiz-Pulido C and
García-Patos Briones V: Melanoma in solid organ transplant
recipients. Actas Dermosifiliogr (Engl Ed). 112:216–224. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Balch CM, Balch GC and Sharma RR:
Identifying early melanomas at higher risk for metastases. J Clin
Oncol. 30:1406–1407. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Song Z, Tu X, Zhou Q, Huang J, Chen Y, Liu
J, Lee S, Kim W, Nowsheen S, Luo K, et al: A novel UCHL3 inhibitor,
perifosine, enhances PARP inhibitor cytotoxicity through inhibition
of homologous recombination-mediated DNA double strand break
repair. Cell Death Dis. 10:3982019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cheng F, Chen H, Zhang L, Li RH, Liu Y and
Sun JF: Inhibition of the NEDD8 conjugation pathway by shRNA to
UBA3, the subunit of the NEDD8-activating enzyme, suppresses the
growth of melanoma cells. Asian Pac J Cancer Prev. 13:57–62. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cheng F, He R, Zhang L, Li H, Zhang W, Ji
X, Kong F, Sun J and Chen S: Expression of neddylation-related
proteins in melanoma cell lines and the effect of neddylation
onmelanoma proliferation. Oncol Lett. 7:1645–1650. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jang MJ, Baek SH and Kim JH: UCH-L1
promotes cancer metastasis in prostate cancer cells through EMT
induction. Cancer Lett. 302:128–135. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li G, Jin X, Zheng J, Jiang N and Shi W:
UCH-L3 promotes non-small cell lung cancer proliferation via
accelerating cell cycle and inhibiting cell apoptosis. Biotechnol
Appl Biochem. 68:165–172. 2021. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song HM, Lee JE and Kim JH: Ubiquitin
C-terminal hydrolase-L3 regulates EMT process and cancer metastasis
in prostate cell lines. Biochem Biophys Res Commun. 452:722–727.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Artavanis-Tsakonas K, Weihofen WA, Antos
JM, Coleman BI, Comeaux CA, Duraisingh MT, Gaudet R and Ploegh HL:
Characterization and structural studies of the Plasmodium
falciparum ubiquitin and Nedd8 hydrolase UCHL3. J Biol Chem.
285:6857–6866. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rabut G and Peter M: Function and
regulation of protein neddylation. ‘Protein modifications: Beyond
the usual suspects’ review series. EMBO Rep. 9:969–976. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Frickel EM, Quesada V, Muething L, Gubbels
MJ, Spooner E, Ploegh H and Artavanis-Tsakonas K: Apicomplexan
UCHL3 retains dual specificity for ubiquitin and Nedd8 throughout
evolution. Cell Microbiol. 9:1601–1610. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luo K, Li L, Li Y, Wu C, Yin Y, Chen Y,
Deng M, Nowsheen S, Yuan J and Lou Z: A
phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51
axis in homologous recombination. Genes Dev. 30:2581–2595. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Enchev RI, Schulman BA and Peter M:
Protein neddylation: Beyond cullin-RING ligases. Nat Rev Mol Cell
Biol. 16:30–44. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen JJ, Schmucker LN and Visco DP Jr:
Identifying de-NEDDylation inhibitors: Virtual high-throughput
screens targeting SENP8. Chem Biol Drug Des. 93:590–604. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mandelker DL, Yamashita K, Tokumaru Y,
Mimori K, Howard DL, Tanaka Y, Carvalho AL, Jiang WW, Park HL, Kim
MS, et al: PGP9.5 promoter methylation is an independent prognostic
factor for esophageal squamous cell carcinoma. Cancer Res.
65:4963–4968. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song Z, Li J, Zhang L, Deng J, Fang Z,
Xiang X and Xiong J: UCHL3 promotes pancreatic cancer progression
and chemo-resistance through FOXM1 stabilization. Am J Cancer Res.
9:1970–1981. 2019.PubMed/NCBI
|
|
18
|
Wang G, Zhang W, Zhou B, Jin C, Wang Z,
Yang Y, Wang Z, Chen Y and Feng X: The diagnosis value of promoter
methylation of UCHL1 in the serum for progression of gastric
cancer. Biomed Res Int. 2015:7410302015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Seliger B, Handke D, Schabel E, Bukur J,
Lichtenfels R and Dammann R: Epigenetic control of the ubiquitin
carboxyl terminal hydrolase 1 in renal cell carcinoma. J Transl
Med. 7:902009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mitsui Y, Shiina H, Hiraki M, Arichi N,
Hiraoka T, Sumura M, Honda S, Yasumoto H and Igawa M: Tumor
suppressor function of PGP9.5 is associated with epigenetic
regulation in prostate cancer-novel predictor of biochemical
recurrence after radical surgery. Cancer Epidemiol Biomarkers Prev.
21:487–496. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brait M, Maldonado L, Noordhuis MG, Begum
S, Loyo M, Poeta ML, Barbosa A, Fazio VM, Angioli R, Rabitti C, et
al: Association of promoter methylation of VGF and PGP9.5 with
ovarian cancer progression. PLoS One. 8:e708782013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kwon J, Wang YL, Setsuie R, Sekiguchi S,
Sakurai M, Sato Y, Lee WW, Ishii Y, Kyuwa S, Noda M, et al:
Developmental regulation of ubiquitin C-terminal hydrolase isozyme
expression during spermatogenesis in mice. Biol Reprod. 71:515–521.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mtango NR, Sutovsky M, Vandevoort CA,
Latham KE and Sutovsky P: Essential role of ubiquitin C-terminal
hydrolases UCHL1 and UCHL3 in mammalian oocyte maturation. J Cell
Physiol. 227:2022–2029. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yi YJ, Sutovsky M, Song WH and Sutovsky P:
Protein deubiquitination during oocyte maturation influences sperm
function during fertilisation, antipolyspermy defense and embryo
development. Reprod Fertil Dev. 27:1154–1167. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Miyoshi Y, Nakayama S, Torikoshi Y, Tanaka
S, Ishihara H, Taguchi T, Tamaki Y and Noguchi S: High expression
of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts
early recurrence in patients with invasive breast cancer. Cancer
Sci. 97:523–529. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rolén U, Kobzeva V, Gasparjan N, Ovaa H,
Winberg G, Kisseljov F and Masucci MG: Masucci, Activity profiling
of deubiquitinating enzymes in cervical carcinoma biopsies and cell
lines. Mol Carcinog. 45:260–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hayashi-Nishino M, Fujita N, Noda T,
Yamaguchi A, Yoshimori T and Yamamoto A: A subdomain of the
endoplasmic reticulum forms a cradle for autophagosome formation.
Nat Cell Biol. 11:1433–1437. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Onorati AV, Dyczynski M, Ojha R and
Amaravadi RK: Targeting autophagy in cancer. Cancer. 124:3307–3318.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Glick D, Barth S and Macleod KF:
Autophagy: Cellular and molecular mechanisms. J Pathol. 221:3–12.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rubinsztein DC, Codogno P and Levine B:
Autophagy modulation as a potential therapeutic target for diverse
diseases. Nat Rev Drug Discov. 11:709–730. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kuma A, Komatsu M and Mizushima N:
Autophagy-monitoring and autophagy-deficient mice. Autophagy.
13:1619–1628. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Martinez-Vicente M and Cuervo AM:
Autophagy and neurodegeneration: When the cleaning crew goes on
strike. Lancet Neurol. 6:352–361. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kirshenbaum LA: Regulation of autophagy in
the heart in health and disease. J Cardiovasc Pharmacol.
60:1092012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
He C, Bassik MC, Moresi V, Sun K, Wei Y,
Zou Z, An Z, Loh J, Fisher J, Sun Q, et al: Exercise-induced
BCL2-regulated autophagy is required for muscle glucose
homeostasis. Nature. 481:511–515. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yousefi S and Simon HU: Autophagy in
cancer and chemotherapy. Results Probl Cell Differ. 49:183–190.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
White E: Deconvoluting the
context-dependent role for autophagy in cancer. Nat Rev Cancer.
12:401–410. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Choi AM, Ryter SW and Levine B: Autophagy
in human health and disease. N Engl J Med. 368:651–662. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tschan MP and Simon HU: The role of
autophagy in anticancer therapy: Promises and uncertainties. J
Intern Med. 268:410–418. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li S, Song Y, Quach C, Guo H, Jang GB,
Maazi H, Zhao S, Sands NA, Liu Q, In GK, et al: Transcriptional
regulation of autophagy-lysosomal function in BRAF-driven melanoma
progression and chemoresistance. Nat Commun. 10:16932019.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu H, He Z and Simon HU: Autophagy
suppresses melanoma tumorigenesis by inducing senescence.
Autophagy. 10:372–373. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sivridis E, Koukourakis MI, Mendrinos SE,
Karpouzis A, Fiska A, Kouskoukis C and Giatromanolaki A: Beclin-1
and LC3A expression in cutaneous malignant melanomas: A biphasic
survival pattern for beclin-1. Melanoma Res. 21:188–195. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lazova R, Klump V and Pawelek J: Autophagy
in cutaneous malignant melanoma. J Cutan Pathol. 37:256–268. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li JX, Yan Q, Liu N, Zheng WJ, Hu M, Yu
ZM, Zhou YD, Wang XW, Liang FX and Chen R: The prognostic value of
autophagy-related markers bclin-1 and LC-3 in colorectal cancers: A
systematic review and meta-analysis. Evid Based Complement Alternat
Med. 2020:84758402020.PubMed/NCBI
|
|
44
|
Li X, He S and Ma B: Autophagy and
autophagy-related proteins in cancer. Mol Cancer. 19:122020.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chu Y, Kang Y, Yan C, Yang C, Zhang T, Huo
H and Liu Y: LUBAC and OTULIN regulate autophagy initiation and
maturation by mediating the linear ubiquitination and the
stabilization of ATG13. Autophagy. 17:1684–1699. 2020. View Article : Google Scholar : PubMed/NCBI
|
